相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
G. E. Konecny et al.
BRITISH JOURNAL OF CANCER (2016)
PARP inhibitors: the race is on
Jessica S. Brown et al.
BRITISH JOURNAL OF CANCER (2016)
c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines
G. L. Gravina et al.
RADIATION RESEARCH (2016)
The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity
Fengmei Cui et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Targeting c-MYC in Platinum-Resistant Ovarian Cancer
Jeyshka M. Reyes-Gonzalez et al.
MOLECULAR CANCER THERAPEUTICS (2015)
MYC impairs resolution of site-specific DNA double-strand breaks repair
Susanna Ambrosio et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2015)
Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions
Valentina Turinetto et al.
NUCLEIC ACIDS RESEARCH (2015)
ATM and ATR as therapeutic targets in cancer
Anika Maria Weber et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways
Sergej Skvortsov et al.
SEMINARS IN CANCER BIOLOGY (2015)
Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation
A. Kumari et al.
CELL DEATH AND DIFFERENTIATION (2015)
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
Alison J. Wiggans et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Targeting the Checkpoint to Kill Cancer Cells
Jan Benada et al.
BIOMOLECULES (2015)
Diminished WNT → β-catenin → c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors
Joseph Juan et al.
GENES & DEVELOPMENT (2014)
The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential
Himisha Beltran
MOLECULAR CANCER RESEARCH (2014)
Bacterial Genome Instability
Elise Darmon et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2014)
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
Carole Beck et al.
NUCLEIC ACIDS RESEARCH (2014)
ATM signalling and cancer
C. A. Cremona et al.
ONCOGENE (2014)
c-MYC-Induced Genomic Instability
Alexandra Kuzyk et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Cancer Stem Cells and Their Mechanism of Chemo-Radiation Resistance
Yonghyun Kim et al.
International Journal of Stem Cells (2014)
ATM activation in hypoxia - causes and consequences
Monica M. Olcina et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Molecular aspects of cancer cell resistance to chemotherapy
Magali Rebucci et al.
BIOCHEMICAL PHARMACOLOGY (2013)
HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia
Simon Wrann et al.
BIOLOGICAL CHEMISTRY (2013)
γH2AX foci formation in the absence of DNA damage: Mitotic H2AX phosphorylation is mediated by the DNA-PKcs/CHK2 pathway
Wen-Zhi Tu et al.
FEBS LETTERS (2013)
Induced Pluripotency and Oncogenic Transformation Are Related Processes
John W. Riggs et al.
STEM CELLS AND DEVELOPMENT (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Small molecules, inhibitors of DNA-PK, targeting DNA repair, and beyond
David Davidson et al.
FRONTIERS IN PHARMACOLOGY (2013)
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Swen Hoelder et al.
MOLECULAR ONCOLOGY (2012)
Cancer stem cells and drug resistance: the potential of nanomedicine
Serguei Vinogradov et al.
NANOMEDICINE (2012)
Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance
Stefano Campaner et al.
CELL DIVISION (2012)
c-Myc Suppression of DNA Double-strand Break Repair
Zhaozhong Li et al.
NEOPLASIA (2012)
E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks
Jie Chen et al.
CELL CYCLE (2011)
c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance
Slovenie Pyndiah et al.
SCIENCE SIGNALING (2011)
The tumorigenicity of human embryonic and induced pluripotent stem cells
Uri Ben-David et al.
NATURE REVIEWS CANCER (2011)
Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair
Kaisa R. Luoto et al.
CANCER RESEARCH (2010)
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells
Keriayn N. Smith et al.
CELL STEM CELL (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage
Lina Guerra et al.
PLOS ONE (2010)
MYC regulation of a poor-prognosis metastatic cancer cell state
Anita Wolfer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Telomere-Centromere-Driven Genomic Instability Contributes to Karyotype Evolution in a Mouse Model of Melanoma
Amanda G. S. Silva et al.
NEOPLASIA (2010)
The Cell Cycle and Myc Intersect with Mechanisms that Regulate Pluripotency and Reprogramming
Amar M. Singh et al.
CELL STEM CELL (2009)
Myc's other life: stem cells and beyond
Elisa Laurenti et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
The combined status of ATM and p53 link tumor development with therapeutic response
Hai Jiang et al.
GENES & DEVELOPMENT (2009)
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi et al.
CANCER CELL (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc Activity
Elisa Laurenti et al.
CELL STEM CELL (2008)
Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis
Christine E. Eyler et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Max-independent functions of Myc in Drosophila melanogaster
Dominik Steiger et al.
NATURE GENETICS (2008)
Genome instability: a mechanistic view of its causes and consequences
Andres Aguilera et al.
NATURE REVIEWS GENETICS (2008)
Transcription-independent functions of MYC: regulation of translation and DNA replication
Michael D. Cole et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
Jialiang Wang et al.
PLOS ONE (2008)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding
Victoria H. Cowling et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells
Che-Pin Lin et al.
ANTI-CANCER DRUGS (2007)
Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis
Fabien Kuttler et al.
SEMINARS IN CANCER BIOLOGY (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
Ming-Jer Huang et al.
EXPERIMENTAL HEMATOLOGY (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
Suma Ray et al.
CANCER RESEARCH (2006)
E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts
F. M. Frame et al.
ONCOGENE (2006)
Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair
HE Bryant et al.
NUCLEIC ACIDS RESEARCH (2006)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
A Wilson et al.
GENES & DEVELOPMENT (2004)
Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy?
L Harrison et al.
ONCOLOGIST (2004)
Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression
A Karlsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells
ZR Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair
YC Chiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genomic targets of the human c-Myc protein
PC Fernandez et al.
GENES & DEVELOPMENT (2003)
Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter
SQ Wu et al.
ONCOGENE (2003)
Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model
DC Knapp et al.
ANTI-CANCER DRUGS (2003)
Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations
LD Rockwood et al.
ONCOGENE (2002)
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
M Jain et al.
SCIENCE (2002)
Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression
S Pelengaris et al.
CELL (2002)
c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability
O Vafa et al.
MOLECULAR CELL (2002)
Chromosome-mediated alterations of the MYC gene in human cancer
NC Popescu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Mre11 complex and DNA replication: Linkage to E2F and sites of DNA synthesist
RS Maser et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Myc drives apoptosis in PC12 cells in the absence of Max
M Wert et al.
ONCOGENE (2001)
Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line
C Leonetti et al.
CANCER GENE THERAPY (2001)
Repression of p15INK4b expression by Myc through association with Miz-1
P Staller et al.
NATURE CELL BIOLOGY (2001)
DNA double-strand breaks: signaling, repair and the cancer connection
KK Khanna et al.
NATURE GENETICS (2001)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
